Cite
MLA Citation
Michael J. Castle et al.. “P2‐027: TARGET ENGAGEMENT IN A PHASE II CLINICAL TRIAL OF AAV2‐NGF GENE THERAPY FOR ALZHEIMER'S DISEASE.” Alzheimer's & dementia, vol. 14, n.d., p. P677. http://access.bl.uk/ark:/81055/vdc_100103406864.0x000021